[SCHEDULE 13G] Catheter Precision, Inc. Passive Investment Disclosure (>5%)
Catheter Precision, Inc. (VTAK) received a Schedule 13G filing from investor Gregory Castaldo reporting a significant passive ownership stake in its common stock.
Rhea-AI Filing Summary
Catheter Precision, Inc. (VTAK) received a Schedule 13G filing from investor Gregory Castaldo reporting a significant passive ownership stake in its common stock. Castaldo reports beneficial ownership of 176,674 shares of common stock, representing 7.5% of the outstanding shares.
The ownership percentage is calculated based on 2,357,127 shares of Catheter Precision common stock outstanding as verified with the company on February 11, 2026. Castaldo reports sole voting and dispositive power over all 176,674 shares and certifies that the shares are not held for the purpose of changing or influencing control of the company.
Positive
- None.
Negative
- None.
AI-generated analysis. How Rhea-AI works. Not financial advice.